GN Hearing will prepare for continued logistical issues with million-dollar injection
In 2022, GN Hearing has put aside a total of DKK 150m (USD 23m) to secure a more robust supply chain. Most production is in China and Malaysia, which means the Danish hearing aid manufacturer is particularly exposed to global challenges. ”This is something that constantly – I’d actually say every day – has our full attention,” CEO Gitte Aabo says.
by ALBERT RØNNING-ANDERSSON, translated by daniel pedersen
With a majority of production in facilities in China and Malaysia, hearing aid manufacturer GN Hearing is particularly exposed to fluctuations in the global supply chain. As the major logistical issues, left by the Covid-19 pandemic, look to continue for some time yet, the company has decided to take things into its own hands.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
GN Hearing will grow by 5–10 percent in 2022
For subscribers
GN Hearing: We are uniquely positioned in the OTC channel
For subscribers
